Key result
Valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) is a feasible and less invasive alternative to reoperation surgical aortic valve replacement for failed surgical bioprostheses.
Why the study?
Bioprosthetic surgical aortic valve failure represents a significant clinical challenge requiring effective intervention, and implementing ViV-TAVI requires careful preparation.
Valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) is a feasible, less invasive alternative to surgical reoperation for failed surgical aortic bioprostheses, provided there is careful preprocedural planning.
ViV-TAVI offers less invasive option for failed bioprosthetic aortic valves; leaves open durability, selection, and outcome questions versus reoperation.
Bioprosthetic surgical aortic valve failure represents a significant clinical challenge that necessitates timely and effective intervention to restore valve function and ensure patient well-being. Use of valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) has emerged as a feasible alternative to reoperation surgical aortic valve replacement (SAVR). By providing a less invasive option, this approach offers the opportunity to reduce the potential risks of a reoperation surgery. However, it is important to note that implementing ViV-TAVI requires careful preparation. This review outlines a thorough approach to ViV-TAVI, encompassing preprocedural planning, valve selection, implantation procedure, and its complications. With the availability of updated clinical data supporting long-term outcomes, this particular strategy is an excellent choice for the treatment of failed surgical aortic bioprostheses.
No takes yet. Share an insight, caveat, or question.
Malakouti et al. (2025) conducted a review in Bioprosthetic surgical aortic valve failure. Valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) vs. Reoperation surgical aortic valve replacement (SAVR) was evaluated. Valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) is a feasible and less invasive alternative to reoperation surgical aortic valve replacement for failed surgical bioprostheses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: